Contact RX MT2 — Melanotan 2 Research Digest

Contact

RX MT2 keeps a reading room for the Melanotan 2 (MT-II) literature, and this desk maintains it. Correspondence is welcome on a few fronts:

Citation corrections. If a citation is broken, a DOI has changed, or a study has been retracted, we want to know. Editorial integrity means the reference list stays current.

Factual corrections. If a finding is misrepresented or a number does not match its source, send the specific citation and the discrepancy.

New research. If a relevant peer-reviewed paper has appeared that we have not covered, send the PMID or DOI. We prioritize Phase I/II human trials, pharmacovigilance publications, and systematic reviews.

We do not field questions about personal use, sourcing, dosing, or clinical consultations. This is a reading room, not a healthcare service; those questions belong with a licensed medical professional.

For editorial correspondence, use the form below.

Contact form fields:

• Name (text)
• Email (email)
• Subject (select: Citation correction / Factual correction / New research / Other editorial)
• Message (textarea)
• Submit button

Responses are editorial only. No clinical, prescriptive, or sourcing guidance will be provided.

RX MT2 offers no medical advice, dosing recommendations, or sourcing information. Everything here is a reading of publicly available peer-reviewed research, nothing more. MT-II has not been approved for human use by any regulatory authority.